{"schema_version":"secwatch.filing_event.v1","accession":"0001650664-23-000005","form_type":"8-K","ticker":"EDIT","cik":"0001650664","company_name":"Editas Medicine, Inc.","filed_at":"2023-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.939614+00:00","generated_at":"2026-06-10T02:29:05.894169+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Editas Medicine CTO and CBO Bruce Eaton to step down Jan 2, 2024","bullets":["Bruce Eaton, EVP, Chief Technology Officer and Chief Business Officer, departs effective January 2, 2024.","Severance includes 12 months base salary, COBRA contributions, and potential 2023 bonus.","Stock option exercise extended to January 2, 2025; performance stock units may vest if metrics met by March 31, 2024.","Separation agreement includes non-disparagement and confidentiality provisions; no successor named."],"urls":{"canonical":"https://secwatch.observer/filing/0001650664-23-000005","json":"https://secwatch.observer/filing/0001650664-23-000005.json","markdown":"https://secwatch.observer/filing/0001650664-23-000005.md","text":"https://secwatch.observer/filing/0001650664-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650664/000165066423000005/0001650664-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650664/000165066423000005/edit-20231003.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T02:29:05.894169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"de35a71127","claim":"Bruce E. Eaton departed as Chief Technology Officer and Chief Business Officer at Editas Medicine, Inc..","evidence_excerpt":"Bruce E. Eaton, Ph.D., Executive Vice President, Chief Technology Officer and Chief Business Officer of the Company, agreed that Dr. Eaton will step down as Chief Technology Officer and Chief Business Officer effective January 2, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066423000005/0001650664-23-000005-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Technology Officer and Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}